Tai Mary Dayne S, Ochoa Lissette, Flydal Marte I, Velasco-Carneros Lorea, Muntaner Jimena, Santiago César, Gamiz-Arco Gloria, Moro Fernando, Jung-Kc Kunwar, Gil-Cantero David, Marcilla Miguel, Kallio Juha P, Muga Arturo, Valpuesta José María, Cuéllar Jorge, Martinez Aurora
Department of Biomedicine, University of Bergen, Bergen, Norway.
Neuro-SysMed Center, Department of Neurology, Haukeland University Hospital, Bergen, Norway.
Nat Commun. 2025 Mar 20;16(1):2755. doi: 10.1038/s41467-025-57733-6.
Pathogenic variants of the J-domain protein DNAJC12 cause parkinsonism, which is associated with a defective interaction of DNAJC12 with tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine biosynthesis. In this work, we characterize the formation of the TH:DNAJC12 complex, showing that DNAJC12 binding stabilizes both TH and the variant TH-p.R202H, associated with TH deficiency. This binding delays their time-dependent aggregation in an Hsp70-independent manner, while preserving TH activity and feedback regulatory inhibition by dopamine. DNAJC12 alone barely activates Hsc70 but synergistically stimulates Hsc70 ATPase activity when complexed with TH. Cryo-electron microscopy supported by crosslinking-mass spectroscopy reveals two DNAJC12 monomers bound per TH tetramer, each embracing one of the two regulatory domain dimers, leaving the active sites available for substrate, cofactor and inhibitory dopamine interaction. Our results also reveal the key role of the C-terminal region of DNAJC12 in TH binding, explaining the pathogenic mechanism of the DNAJC12 disease variant p.W175Ter.
J结构域蛋白DNAJC12的致病变体可导致帕金森症,这与DNAJC12与酪氨酸羟化酶(TH)之间的缺陷性相互作用有关,酪氨酸羟化酶是多巴胺生物合成中的限速酶。在这项研究中,我们对TH:DNAJC12复合物的形成进行了表征,结果表明DNAJC12的结合可稳定TH以及与TH缺乏相关的变体TH-p.R202H。这种结合以不依赖Hsp70的方式延迟了它们随时间的聚集,同时保留了TH的活性以及多巴胺的反馈调节抑制作用。单独的DNAJC12几乎不激活Hsc70,但与TH复合时可协同刺激Hsc70的ATPase活性。交联质谱支持的冷冻电子显微镜显示,每个TH四聚体结合两个DNAJC12单体,每个单体环绕两个调节结构域二聚体之一,使活性位点可用于底物、辅因子和抑制性多巴胺的相互作用。我们的结果还揭示了DNAJC12的C末端区域在TH结合中的关键作用,解释了DNAJC12疾病变体p.W175Ter的致病机制。